AAAAAA
Results:
1-22
|
Results: 22
Authors:
GAW A
Citation: A. Gaw, EVIDENCE BASED APPROACH FOR THE MANAGEMENT OF MIXED HYPERLIPIDEMIA, Atherosclerosis (Amsterdam), 137, 1998, pp. 97-100
Authors:
CUCHEL M
STOTT D
BELL L
GAW A
MCCONNELL M
SHEPHERD J
PACKARD CJ
VERGANI C
Citation: M. Cuchel et al., HIGH PLASMA LP(A) LEVELS AND LOW PLASMA HDL-CHOLESTEROL LEVELS AS RISK-FACTORS FOR CEREBROVASCULAR-DISEASE IN ELDERLY MEN AND WOMEN, Atherosclerosis, 134(1-2), 1997, pp. 173-173
Authors:
GAW A
Citation: A. Gaw, EVIDENCE BASED APPROACH FOR THE MANAGEMENT OF MINED HYPERLIPIDEMIA, Atherosclerosis, 130, 1997, pp. 88-88
Authors:
GAW A
GOURLAY CWD
BROWN EA
BELL MA
Citation: A. Gaw et al., EVALUATION OF A NEW AUTOMATED LATEX AGGLUTINATION ASSAY FOR LIPOPROTEIN(A) - COMPARISON WITH A MANUAL ELISA, Clinica chimica acta, 261(2), 1997, pp. 175-183
Authors:
DEMANT T
GUTLICH K
BEDYNECK A
SCHWERTFEGER G
GAW A
PACKARD CJ
SEIDEL D
Citation: T. Demant et al., IN-VIVO STUDIES OF HUMAN LIPOPROTEIN(A) METABOLISM BY USE OF A STABLE-ISOTOPE TRACER TECHNIQUE, Circulation, 96(8), 1997, pp. 1246-1246
Authors:
GAW A
PACKARD CJ
LINDSAY GM
MURRAY EF
GRIFFIN BA
CASLAKE MJ
COLQUHOUN I
WHEATLEY DJ
LORIMER AR
SHEPHERD J
Citation: A. Gaw et al., EFFECTS OF COLESTIPOL ALONE AND IN COMBINATION WITH SIMVASTATIN ON APOLIPOPROTEIN-B METABOLISM, Arteriosclerosis, thrombosis, and vascular biology, 16(2), 1996, pp. 236-249
Authors:
SATTAR N
GAW A
PACKARD CJ
GREER IA
Citation: N. Sattar et al., POTENTIAL PATHOGENIC ROLES OF ABERRANT LIPOPROTEIN AND FATTY-ACID METABOLISM IN PREECLAMPSIA, British journal of obstetrics and gynaecology, 103(7), 1996, pp. 614-620
Authors:
GAW A
Citation: A. Gaw, THE STATIN TRIALS - CLOSING ARGUMENTS IN THE CASE AGAINST CHOLESTEROL, Scottish Medical Journal, 41(4), 1996, pp. 99-100
Authors:
GAW A
Citation: A. Gaw, CAN THE CLINICAL EFFICACY OF THE HMG COA REDUCTASE INHIBITORS BE EXPLAINED SOLELY BY THEIR EFFECTS ON LDL-CHOLESTEROL, Atherosclerosis, 125(2), 1996, pp. 267-269
Authors:
SATTAR NA
GAW A
Citation: Na. Sattar et A. Gaw, MINERALOCORTICOID EFFECTS OF HIGH-DOSE HYDROCORTISONE, BMJ. British medical journal, 311(6999), 1995, pp. 260-260
Authors:
SATTAR NA
GAW A
Citation: Na. Sattar et A. Gaw, RISK OF CORONARY HEART-DISEASE IN ASIAN WOMEN, BMJ. British medical journal, 310(6977), 1995, pp. 466-467
Authors:
GAW A
MANCINI FP
ISHIBASHI S
Citation: A. Gaw et al., RAPID GENOTYPING OF LOW-DENSITY-LIPOPROTEIN RECEPTOR KNOCKOUT MICE USING A POLYMERASE CHAIN-REACTION TECHNIQUE, Laboratory animals, 29(4), 1995, pp. 447-449
Authors:
GAW A
PACKARD CJ
LINDSAY GM
GRIFFIN BA
CASLAKE MJ
LORIMER AR
SHEPHERD J
Citation: A. Gaw et al., OVERPRODUCTION OF SMALL VERY-LOW-DENSITY LIPOPROTEINS (S-F-20-60) IN MODERATE HYPERCHOLESTEROLEMIA - RELATIONSHIPS BETWEEN APOLIPOPROTEIN-BKINETICS AND PLASMA-LIPOPROTEINS, Journal of lipid research, 36(1), 1995, pp. 158-171
Authors:
PACKARD CJ
GAW A
DEMANT T
SHEPHERD J
Citation: Cj. Packard et al., DEVELOPMENT AND APPLICATION OF A MULTICOMPARTMENTAL MODEL TO STUDY VERY-LOW-DENSITY LIPOPROTEIN SUBFRACTION METABOLISM, Journal of lipid research, 36(1), 1995, pp. 172-187
Authors:
GAW A
CHIESA G
Citation: A. Gaw et G. Chiesa, CHARACTERIZATION OF COMMERCIAL ANTIBODIES FOR USE IN HIGH-RESOLUTION APO(A) PHENOTYPING BY IMMUNOBLOT ANALYSIS, Clinica chimica acta, 240(1), 1995, pp. 75-81
Authors:
GAW A
Citation: A. Gaw, REPORT OF THE ELECTIONS COMMITTEE, The American journal of psychiatry, 152(10), 1995, pp. 1556-1556
Authors:
GAW A
Citation: A. Gaw, LIPOPROTEIN(A) AND RISK OF MYOCARDIAL-INFARCTION, JAMA, the journal of the American Medical Association, 271(14), 1994, pp. 1077-1077
Authors:
GAW A
BOERWINKLE E
COHEN JC
HOBBS HH
Citation: A. Gaw et al., COMPARATIVE-ANALYSIS OF THE APO(A) GENE, APO(A) GLYCOPROTEIN, AND PLASMA-CONCENTRATIONS OF LP(A) IN 3 ETHNIC-GROUPS - EVIDENCE FOR NO COMMON LP(A) ALLELE AT THE APO(A) LOCUS, The Journal of clinical investigation, 93(6), 1994, pp. 2526-2534
Authors:
GAW A
PACKARD CJ
CASLAKE MJ
GRIFFIN BA
LINDSAY GM
THOMSON J
VALLANCE BD
WOSORNU D
SHEPHERD J
Citation: A. Gaw et al., EFFECTS OF CIPROFIBRATE ON LDL METABOLISM IN MAN, Atherosclerosis, 108(2), 1994, pp. 137-148
Authors:
CASLAKE MJ
PACKARD CJ
GAW A
MURRAY E
GRIFFIN BA
VALLANCE BD
SHEPHERD J
Citation: Mj. Caslake et al., FENOFIBRATE AND LDL METABOLIC HETEROGENEITY IN HYPERCHOLESTEROLEMIA, Arteriosclerosis and thrombosis, 13(5), 1993, pp. 702-711
Authors:
PACKARD CJ
SHEPHERD J
LINDSAY GM
GAW A
TASKINEN MR
Citation: Cj. Packard et al., THYROID REPLACEMENT THERAPY AND ITS INFLUENCE ON POSTHEPARIN PLASMA LIPASES AND APOLIPOPROTEIN-B METABOLISM IN HYPOTHYROIDISM, The Journal of clinical endocrinology and metabolism, 76(5), 1993, pp. 1209-1216
Authors:
SHEPHERD J
CASLAKE M
GAW A
GRIFFIN B
LINDSAY G
PACKARD C
Citation: J. Shepherd et al., ATHEROGENICITY OF TRIGLYCERIDE-RICH LIPOPROTEINS, Annales de biologie clinique, 51(3-5), 1993, pp. 260-262
Risultati:
1-22
|